NorthWest Biotherapeutics Inc (NWBO)

[LearningEveryTrade]

This is why Duffy was at NWBO...
ZERO mention of merger...

Dr. Duffy commented “My years at Merck, from inception of the Keytruda programs, have been exciting and invaluable. As I look forward now to the next wave of advances in immune therapies for cancer, I am excited about the potential of NW Bio’s DCVax technologies to deliver new breakthroughs for patients. I hope to build on my experience in immuno-oncology and my network of relationships in the field to help NW Bio achieve this potential.”

Linda Powers, CEO of NW Bio, noted that “Dr. Duffy’s experience with immune therapies for cancer and one of the most successful product development programs in the field will be an invaluable addition to our team. We at NW Bio could not be more excited about Dr. Duffy’s choice to join us and help realize the broad potential of DCVax.”

https://nwbio.com/nw-bio-expands-senior-management-team-with-dr-kevin-duffy-as-vice-president-medical-affairs-external-collaborations/